Bellingham Fit for Real Madrid vs Bayern UCL Clash https://lrivo.com/bellingham-fit-for-real-madrid-vs-bayern-ucl-clash
Jude Bellingham returns from injury as Real Madrid face Bayern Munich in a must-win Champions League tie. See how his presence changes everything.
Iran presented the US with a 14-point peace plan https://ymaho.com/iran-presented-the-us-with-a-14-point-peace-plan
Tehran demanded reparations, troop withdrawal, and a new status for the Strait of Hormuz from the US. Learn the details of the ultimatum and Washington's reaction.
Iran presented the US with a 14-point ultimatum https://ymaho.com/iran-presented-the-us-with-a-14-point-ultimatum
Tehran rejected the US proposal for de-escalation and put forward a counter '14-point plan'. Find out why this is a political trap for Trump and how the crisis will change oil prices. Read analysis.
Intellia CRISPR therapy: phase 3 data on edema — breakthrough https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough
Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.
CRISPR Therapy HAE: Phase 3 Data from Intellia at EAACI 2026 https://ymaho.com/crispr-therapy-hae-phase-3-data-from-intellia-at-eaaci-2026
Intellia presented the long-awaited results of phase 3 of CRISPR therapy lonvoguran ziclumeran for hereditary angioedema. Reduction of attacks by 87%, 62% of patients without therapy. Learn more.
TaShe Skin First: Conscious Care at Sochi Fashion Week 2026 https://ymaho.com/tashe-skin-first-conscious-care-at-sochi-fashion-week-2026
Belarusian brand TaShe presented the Skin First philosophy at Sochi Fashion Week. Find out why conscious care is replacing decorative cosmetics. Read expert analysis.
Kelp Hack: Two Scenarios of Aave Crisis https://ymaho.com/kelp-hack-two-scenarios-of-aave-crisis
LlamaRisk analysts presented two scenarios for solving Aave's problems after the Kelp bridge hack of $293 million. Find out how this will affect the market and your assets.
CRISPR gene editing: treatment of hypertriglyceridemia CTX310 https://ymaho.com/crispr-gene-editing-treatment-of-hypertriglyceridemia-ctx310
CRISPR Therapeutics presented CTX310 — a one-time gene therapy that reduces triglycerides by 82% and LDL by 86%. Learn about the revolution in dyslipidemia treatment and market prospects.
Epigenome editing of aging: results of SynBioBeta 2026 https://ymaho.com/epigenome-editing-of-aging-results-of-synbiobeta-2026
At SynBioBeta 2026, cell stability engineering was presented: AI mapping of aging and proteostasis editing for treating age-related diseases. Learn the details of the breakthrough.